Covaxin received the Drugs Controller General of India (DCGI) nod to conduct clinical trials in children on May 11. “Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years.”
India started the world’s largest vaccination drive on January 16 this year in a phased manner with healthcare workers (HCWs) getting inoculated first and the vaccination of frontline workers (FLWs) started on February 2.
EU has delayed putting the UK on the “white list” amid concerns about the rise in cases linked to the Delta variant. Japan, which is in an extended state of emergency during which there has been a sustained reduction in the number of new infections has been added to the list, reported The Guardian.
Meanwhile, the Rajasthan government cancelled Class 10 and Class 12th state board exams in the wake of the deadly second wave. The decision, taken in an online meeting of the State Council of Ministers, came a day after the central government announced cancelling the CBSE Class 12 board exams.
Medical experts have warned that children may be more prone to infection in a possible third wave of COVID-19. Rajasthan School Education Minister Govind Singh Dotasra tweeted, “In view of the fear of the third wave of corona, the Council of Ministers in the meeting decided to cancel the board examinations of class 10 and 12 of Rajasthan Board of Secondary Education today in the interest of students. A decision regarding marking will be taken soon.”
Read all the Latest News, Breaking News and Coronavirus News here
This article includes sponsored content. The views expressed are those of the sponsor and do not necessarily reflect the official policy or position of our publication.